ArticleEuropean radiology2024

Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model.

Yiwei Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.